Strong association of serum-and glucocorticoid-regulated kinase 1 with peripheral and adipose tissue inflammation in obesity

International Journal of Obesity

Volumn 39, Issue 7, 2015, Pages 1143-1150

  Schernthaner Reiter, M H ^a   Kiefer, F ^a   Zeyda, M ^a   Stulnig, T M ^a   Luger, A ^a   Vila, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; LEPTIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CELL MATURATION; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE ASSOCIATION; ENZYME INDUCTION; ENZYME REGULATION; GONAD; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; SUBCUTANEOUS TISSUE; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; DISEASE MODEL; IMMUNOBLOTTING; METABOLISM; MORBID OBESITY;

MURINAE;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; OBESITY, MORBID; PROTEIN-SERINE-THREONINE KINASES;

EID: 84936847254     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.41     Document Type: Article

References (30)

1. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings A. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 1999; 18: 3024-3033.
2. Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N et al. Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med (Berl) 2006; 84: 737-746.
3. Lang F, Stournaras C, Alesutan I. Regulation of transport across cell membranes by the serum-and glucocorticoid-inducible kinase SGK1. Mol Membr Biol 2014; 31: 29-36.
4. Palmada M, Boehmer C, Akel A, Rajamanickam J, Jeyaraj S, Keller K et al. SGK1 kinase upregulates GLUT1 activity and plasma membrane expression. Diabetes 2006; 55: 421-427.
5. Dieter M, Palmada M, Rajamanickam J, Aydin A, Busjahn A, Boehmer C et al. Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes Res 2004; 12: 862-870.
6. Fujita Y, Kojima H, Hidaka H, Fujimiya M, Kashiwagi A, Kikkawa R. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. Diabetologia 1998; 41: 1459-1466.
7. Heikamp EB, Patel CH, Collins S, Waickman A, Oh MH, Sun IH et al. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat Immunol 2014; 15: 457-464.
8. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
9. Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013; 22: 701-714.
10. Li P, Pan F, Hao Y, Feng W, Song H, Zhu D. SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes. Diabetes Res Clin Pract 2013; 102: 35-42.
11. Di Pietro N, Panel V, Hayes S, Bagattin A, Meruvu S, Pandolfi A et al. Serum-and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1. Mol Endocrinol 2010; 24: 370-380.
12. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
13. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993-997.
14. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007; 354: 45-49.
15. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009; 33: 54-66.
16. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-850.
17. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
18. Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 2008; 93: 3215-3221.
19. Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T et al. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 2008; 149: 1350-1357.
20. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007; 31: 1420-1428.
21. Nabokikh A, Ilhan A, Bilban M, Gartner W, Vila G, Niederle B et al. Reduced TGFbeta1 expression and its target genes in human insulinomas. Exp Clin Endocrinol Diabetes 2007; 115: 674-682.
22. Reiter MH, Vila G, Knosp E, Baumgartner-Parzer SM, Wagner L, Stalla GK et al. Opposite effects of serum-and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release. Am J Physiol Endocrinol Metab 2011; 301: E336-E341.
23. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81: 1607-1613.
24. Nishida Y, Nagata T, Takahashi Y, Sugahara-Kobayashi M, Murata A, Asai S. Alteration of serum/glucocorticoid regulated kinase-1 (sgk-1) gene expression in rat hippocampus after transient global ischemia. Brain Res Mol Brain Res. 2004; 123: 121-125.
25. Rusai K, Wagner B, Roos M, Schmaderer C, Strobl M, Boini KM et al. The serum and glucocorticoid-regulated kinase 1 in hypoxic renal injury. Cell Physiol Biochem 2009; 24: 577-584.
26. Kobayashi T, Cohen P. Activation of serum-and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 1999; 339: 319-328.
27. Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007; 292: E166-E174.
28. Cowling RT, Birnboim HC. Expression of serum-and glucocorticoid-regulated kinase (sgk) mRNA is up-regulated by GM-CSF and other proinflammatory mediators in human granulocytes. J Leukoc Biol 2000; 67: 240-248.
29. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014; 41: 36-48.
30. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.